The role of gut hormone peptide YY in energy and glucose homeostasis: Twelve years on

Annual Review of Physiology

Volumn 76, Issue , 2014, Pages 585-608

  Manning, Sean ^a   Batterham, Rachel L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bariatric surgery; Hepatoportal; Obesity; Postprandial; Reward

Indexed keywords

ADULT; ANIMALS; BARIATRIC SURGERY; ENERGY METABOLISM; EXERCISE; FEMALE; GLUCOSE; HOMEOSTASIS; HUMANS; MALE; OBESITY; PEPTIDE YY; WEIGHT LOSS;

EID: 84894205037     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-021113-170404     Document Type: Review

References (149)

1. Tatemoto K. 1982. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc. Natl. Acad. Sci. USA 79:2514-188
2. Naruse S, Kitagawa M, Ishiguro H, Hayakawa T. 2002. Feedback regulation of pancreatic secretion by peptide YY. Peptides 23:359-655
3. Yang H. 2002. Central and peripheral regulation of gastric acid secretion by peptide YY. Peptides 23:349-588
4. Imamura M. 2002. Effects of surgical manipulation of the intestine on peptide YY and its physiology. Peptides 23:403-77
5. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, et al. 2002. Gut hormone PYY336 physiologically inhibits food intake. Nature 418:650-544
6. Chandarana K, Batterham R. 2008. Peptide YY. Curr. Opin. Endocrinol., Diabetes, Obes. 15:65-722
7. Kirchner H, Tong J, Tschop MH, Pfluger PT. 2010. Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants. Am. J. Physiol. Endocrinol. Metab. 298:E909-199
8. Tschop M, Castaneda TR, Joost HG, Thone-Reineke C, Ortmann S, et al. 2004. Physiology: does gut hormone PYY3-36 decrease food intake in rodents? Nature 430; doi:10.1038/nature026655
9. Coll AP, Farooqi IS, O'Rahilly S. 2007. The hormonal control of food intake. Cell 129:251-622
10. Gribble FM. 2012. The gut endocrine system as a coordinator of postprandial nutrient homeostasis. Proc. Nutr. Soc. 71:456-622
11. Hussain SS, Bloom SR. 2013. The regulation of food intake by the gut-brain axis: implications for obesity. Int. J. Obes. 37:625-333
12. Habib AM, Richards P, Rogers GJ, Reimann F, Gribble FM. 2013. Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells. Diabetologia 56:1413-166
13. Kim BJ, Carlson OD, Jang HJ, Elahi D, Berry C, Egan JM. 2005. Peptide YY is secreted after oral glucose administration in a gender-specific manner. J. Clin. Endocrinol. Metab. 90:6665-711
14. Egerod KL, Engelstoft MS, Grunddal KV, Nohr MK, Secher A, et al. 2012. A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology 153:5782-955
15. Habib AM, Richards P, Cairns LS, Rogers GJ, Bannon CA, et al. 2012. Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry. Endocrinology 153:3054-655
16. Grandt D, SchimiczekM, Beglinger C, Layer P, GoebellH, et al. 1994. Twomolecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY1-36 and PYY3-36. Regul. Pept. 51:151-99
17. Batterham RL, Heffron H, Kapoor S, Chivers JE, Chandarana K, et al. 2006. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab. 4:223-333
18. Mentlein R, Dahms P,GrandtD, Kruger R. 1993. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul. Pept. 49:133-444
19. Unniappan S, McIntosh CH, Demuth HU, Heiser U, Wolf R, Kieffer TJ. 2006. Effects of dipeptidyl peptidase IV on the satiety actions of peptide YY. Diabetologia 49:1915-233
20. Gorrell MD, Gysbers V, McCaughan GW. 2001. CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand. J. Immunol. 54:249-644
21. Sloth B, Davidsen L, Holst JJ, Flint A, Astrup A. 2007. Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males. Am. J. Physiol. Endocrinol. Metab. 293:E604-99
22. Sloth B,Holst JJ, Flint A,Gregersen NT, Astrup A. 2007. Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. Am. J. Physiol. Endocrinol. Metab. 292:E1062-688
23. Boey D, Sainsbury A,HerzogH. 2007. The role of peptide YY in regulating glucose homeostasis. Peptides 28:390-955
24. Chandarana K, Gelegen C, Irvine EE, Choudhury AI, Amouyal C, et al. 2013. Peripheral activation of the Y2-receptor promotes secretion of GLP-1 and improves glucose tolerance. Mol. Metab. 2:142-522
25. WaltherC,MorlK, Beck-Sickinger AG. 2011. Neuropeptide Y receptors: Ligand binding and trafficking suggest novel approaches in drug development. J. Pept. Sci. 17:233-466
26. Chan JL,Mun EC, Stoyneva V, Mantzoros CS, Goldfine AB. 2006. Peptide YY levels are elevated after gastric bypass surgery. Obesity 14:194-988
27. Batterham RL, ffytche DH, Rosenthal JM, Zelaya FO, Barker GJ, et al. 2007. PYYmodulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 450:106-99
28. le Roux CW, Batterham RL, Aylwin SJ, Patterson M, Borg CM, et al. 2006. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147:3-88
29. Belza A, Ritz C, Sorensen MQ, Holst JJ, Rehfeld JF, Astrup A. 2013. Contribution of gastroenteropancreatic appetite hormones to protein-induced satiety. Am. J. Clin. Nutr. 97:980-899
30. Essah PA, Levy JR, Sistrun SN, Kelly SM, Nestler JE. 2007. Effect of macronutrient composition on postprandial peptide YY levels. J. Clin. Endocrinol. Metab. 92:4052-555
31. Heden TD, Liu Y, Sims L, Kearney ML, Whaley-Connell AT, et al. 2013. Liquid meal composition, postprandial satiety hormones, and perceived appetite and satiety in obese women during acute caloric restriction. Eur. J. Endocrinol. 168:593-6000
32. ScottWR, Batterham RL. 2011. Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301:R15-277
33. Chandarana K, Batterham RL. 2012. Shedding pounds after going under the knife: metabolic insights from cutting the gut. Nat. Med. 18:668-699
34. NearyMT, Batterham RL. 2010. Gaining new insights into food reward with functional neuroimaging. Forum Nutr. 63:152-633
35. Stensel D. 2010. Exercise, appetite and appetite-regulating hormones: implications for food intake and weight control. Ann. Nutr. Metab. 57(Suppl. 2):36-422
36. Korner J, InabnetW, Conwell IM, Taveras C, Daud A, et al. 2006. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity 14:1553-611
37. Tsilchorozidou T, Batterham RL, Conway GS. 2008. Metformin increases fasting plasma peptide tyrosine tyrosine (PYY) in women with polycystic ovarian syndrome (PCOS). Clin. Endocrinol. 69:936-422
38. Kirino Y, SeiM,KawazoeK,Minakuchi K, Sato Y. 2012. Plasma dipeptidyl peptidase 4 activity correlates with body mass index and the plasma adiponectin concentration in healthy young people. Endocr. J. 59:949-533
39. Alam ML, Van der Schueren BJ, Ahren B,Wang GC, Swerdlow NJ, et al. 2011. Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase-4 activity in obese patients with type 2 diabetes. Diabetes Obes. Metab. 13:378-811
40. Chandarana K, Drew ME, Emmanuel J, Karra E, Gelegen C, et al. 2009. Subject standardization, acclimatization, and sample processing affect gut hormone levels and appetite in humans. Gastroenterology 136:2115-266
41. Gelegen C, Chandarana K, Choudhury AI, Al-QassabH, Evans IM, et al. 2012. Regulation of hindbrain Pyy expression by acute food deprivation, prolonged caloric restriction, and weight loss surgery in mice. Am. J. Physiol. Endocrinol. Metab. 303:E659-688
42. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, et al. 2003. Inhibition of food intake in obese subjects by peptide YY3-36. N. Engl. J. Med. 349:941-488
43. Boey D, Lin S,KarlT,BaldockP,Lee N, et al. 2006. PeptideYYablation inmice leads to the development of hyperinsulinaemia and obesity. Diabetologia 49:1360-700
44. Chandarana K, Gelegen C, Karra E, Choudhury AI, Drew ME, et al. 2011. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY. Diabetes 60:810-188
45. Lovshin JA, Drucker DJ. 2009. Incretin-based therapies for type 2 diabetes mellitus. Nat. Rev. Endocrinol. 5:262-699
46. Speakman JR, Levitsky DA, Allison DB, Bray MS, de Castro JM, et al. 2011. Set points, settling points and some alternative models: theoretical options to understand how genes and environments combine to regulate body adiposity. Dis. Model. Mech. 4:733-455
47. Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, et al. 2011. Long-term persistence of hormonal adaptations to weight loss. N. Engl. J. Med. 365:1597-6044
48. Larder R, O'Rahilly S. 2012. Shedding pounds after going under the knife: guts over glory -why diets fail. Nat. Med. 18:666-677
49. Sjostrom L. 2013. Review of the key results from the Swedish Obese Subjects (SOS) trial -a prospective controlled intervention study of bariatric surgery. J. Intern. Med. 273:219-344
50. Mechanick JI, Youdim A, Jones DB,Garvey WT, Hurley DL, et al. 2013. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient -2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg. Obes. Relat. Dis. 9:159-911
51. Buchwald H, Oien DM. 2013. Metabolic/bariatric surgery worldwide 2011. Obes. Surg. 23:427-366
52. Tam CS, Berthoud HR, Bueter M, Chakravarthy MV, Geliebter A, et al. 2011. Could the mechanisms of bariatric surgery hold the key for novel therapies? Report from a Pennington Scientific Symposium. Obes. Rev. 12:984-944
53. Laurenius A, Larsson I, BueterM,Melanson KJ, Bosaeus I, et al. 2012. Changes in eating behaviour and meal pattern following Roux-en-Y gastric bypass. Int. J. Obes. 36:348-555
54. Melissas J, Daskalakis M, Koukouraki S, Askoxylakis I, Metaxari M, et al. 2008. Sleeve gastrectomy: a "food limiting" operation. Obes. Surg. 18:1251-566
55. Korner J, Bessler M, Cirilo LJ, Conwell IM, Daud A, et al. 2005. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J. Clin. Endocrinol. Metab. 90:359-655
56. le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, et al. 2006. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann. Surg. 243:108-144
57. Morinigo R, Moize V, MusriM, Lacy AM,Navarro S, et al. 2006. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J. Clin. Endocrinol. Metab. 91:1735-400
58. Morinigo R, Vidal J, Lacy AM, Delgado S, Casamitjana R, Gomis R. 2008. Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects. Ann. Surg. 247:270-755
59. Olivan B, Teixeira J, BoseM, Bawa B, Chang T, et al. 2009. Effect of weight loss by diet or gastric bypass surgery on peptide YY336 levels. Ann. Surg. 249:948-533
60. Bose M, Machineni S, Olivan B, Teixeira J, McGinty JJ, et al. 2010. Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding. Obesity 18:1085-911
61. Jacobsen SH,Olesen SC, DirksenC, Jorgensen NB, Bojsen-MollerKN, et al. 2012. Changes in gastrointestinal hormone responses, insulin sensitivity, and β-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes. Surg. 22:1084-966
62. le Roux CW,Welbourn R,WerlingM, Osborne A, Kokkinos A, et al. 2007. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann. Surg. 246:780-855
63. Valderas JP, Irribarra V, Boza C, de la Cruz R, Liberona Y, et al. 2010. Medical and surgical treatments for obesity have opposite effects on peptide YY and appetite: a prospective study controlled for weight loss. J. Clin. Endocrinol. Metab. 95:1069-755
64. Pournaras DJ, Osborne A, Hawkins SC, Mahon D, Ghatei MA, et al. 2010. The gut hormone response following Roux-en-Y gastric bypass: cross-sectional and prospective study. Obes. Surg. 20:56-600
65. Naslund E, Gryback P, Hellstrom PM, Jacobsson H, Holst JJ, et al. 1997. Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass formassive obesity. Int. J. Obes. Relat.Metab.Disord. 21:387-922
66. Werling M, Olbers T, Fandriks L, Bueter M, Lonroth H, et al. 2013. Increased postprandial energy expenditure may explain superior long term weight loss after Roux-en-Y gastric bypass compared to vertical banded gastroplasty. PLoS ONE 8:e602800
67. Laferrere B. 2011. Diabetes remission after bariatric surgery: Is it just the incretins? Int. J. Obes. 35(Suppl. 3):22-255
68. Dirksen C, Damgaard M, Bojsen-Moller KN, Jorgensen NB, Kielgast U, et al. 2013. Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass. Neurogastroenterol. Motil. 25:346-e2555
69. Pournaras DJ, Aasheim ET, Bueter M, Ahmed AR, Welbourn R, et al. 2012. Effect of bypassing the proximal gut on gut hormones involved with glycemic control and weight loss. Surg. Obes. Relat. Dis. 8:371-744
70. Peterli R, Steinert RE, Woelnerhanssen B, Peters T, Christoffel-Courtin C, et al. 2012. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes. Surg. 22:740-488
71. Basso N, Capoccia D, Rizzello M, Abbatini F, Mariani P, et al. 2011. First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis. Surg. Endosc. 25:3540-500
72. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. 2008. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann. Surg. 247:401-77
73. Ramon JM, Salvans S, Crous X, Puig S, Goday A, et al. 2012. Effect of Roux-en-Y gastric bypass versus sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial. J. Gastrointest. Surg. 16:1116-222
74. Melissas J, Koukouraki S, Askoxylakis J, Stathaki M, Daskalakis M, et al. 2007. Sleeve gastrectomy: a restrictive procedure? Obes. Surg. 17:57-622
75. Pilichiewicz AN,LittleTJ, Brennan IM, Meyer JH, Wishart JM, et al. 2006. Effects of load, and duration, of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290:R668-777
76. Buchan AM, Pederson RA, Koop I, Gourlay RH, Cleator IG. 1993. Morphological and functional alterations to a sub-group of regulatory peptides in human pancreas and intestine after jejuno-ileal bypass. Int. J. Obes. Relat. Metab. Disord. 17:109-133
77. Mumphrey MB, Patterson LM, Zheng H, Berthoud HR. 2013. Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats. Neurogastroenterol. Motil. 25:e70-799
78. Korner J, Inabnet W, Febres G, Conwell IM, McMahon DJ, et al. 2009. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int. J. Obes. 33:786-955
79. Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG, Aylwin SJ. 2006. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br. J. Surg. 93:210-155
80. Fenske WK, BueterM,Miras AD, Ghatei MA, Bloom SR, le Roux CW. 2012. Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass. Int. J. Obes. 36:379-844
81. Stefater MA, Wilson-Perez HE, Chambers AP, Sandoval DA, Seeley RJ. 2012. All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr. Rev. 33:595-6222
82. Seyfried F, le Roux CW, Bueter M. 2011. Lessons learned from gastric bypass operations in rats. Obes. Facts 4(Suppl. 1):3-122
83. Strader AD, Vahl TP, Jandacek RJ, Woods SC,D'Alessio DA, Seeley RJ. 2005. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am. J. Physiol. Endocrinol. Metab. 288:E447-533
84. Chelikani PK, Shah IH, Taqi E, Sigalet DL, Koopmans HH. 2010. Comparison of the effects of Rouxen-Y gastric bypass and ileal transposition surgeries on food intake, body weight, and circulating peptide YY concentrations in rats. Obes. Surg. 20:1281-888
85. Patel RT, Shukla AP, Ahn SM, MoreiraM, Rubino F. 2013. Surgical control of obesity and diabetes: the role of intestinal versus gastric mechanisms in the regulation of body weight and glucose homeostasis. Obesity. doi: 10.1002/oby.204411
86. Drucker DJ. 2007. The role of gut hormones in glucose homeostasis. J. Clin. Investig. 117:24-322
87. Bottcher G, Ahren B, Lundquist I, Sundler F. 1989. Peptide YY: intrapancreatic localization and effects on insulin and glucagon secretion in the mouse. Pancreas 4:282-888
88. Upchurch BH, Aponte GW, Leiter AB. 1994. Expression of peptide YY in all four islet cell types in the developing mouse pancreas suggests a common peptide YY-producing progenitor. Development 120:245-522
89. Sam AH, Gunner DJ, King A, Persaud SJ, Brooks L, et al. 2012. Selective ablation of peptide YY cells in adult mice reveals their role in βcell survival. Gastroenterology 143:459-688
90. Nieuwenhuizen AG, Karlsson S, Fridolf T, Ahren B. 1994. Mechanisms underlying the insulinostatic effect of peptide YY in mouse pancreatic islets. Diabetologia 37:871-788
91. Boey D, Heilbronn L, Sainsbury A, Laybutt R, Kriketos A, et al. 2006. Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes. Neuropeptides 40:317-244
92. Burcelin R, Brunner H, Seydoux J, Thorensa B, Pedrazzini T. 2001. Increased insulin concentrations and glucose storage in neuropeptide Y Y1 receptor-deficient mice. Peptides 22:421-277
93. van den Hoek AM, Heijboer AC, Corssmit EP, Voshol PJ, Romijn JA, et al. 2004. PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet. Diabetes 53:1949-522
94. Ortiz AA, Milardo LF, DeCarr LB, Buckholz TM, Mays MR, et al. 2007. A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents. J. Pharmacol. Exp. Ther. 323:692-7000
95. Pittner RA, Moore CX, Bhavsar SP, Gedulin BR, Smith PA, et al. 2004. Effects of PYY336 in rodent models of diabetes and obesity. Int. J. Obes. Relat. Metab. Disord. 28:963-711
96. Abbott CR, Small CJ, Kennedy AR, Neary NM, Sajedi A, et al. 2005. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY336 on food intake. Brain Res. 1043:139-444
97. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, et al. 2002. Gut hormone PYY3-36 physiologically inhibits food intake. 418:650-544
98. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, et al. 2003. Inhibition of food intake in obese subjects by peptide YY3-36. N. Engl. J. Med. 349:941-488
99. Sloth B,Holst JJ, Flint A, Gregersen NT, Astrup A. 2007. Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. Am. J. Physiol. Endocrinol. Metab. 292:E1062-688
100. Ahren B, Larsson H. 1996. Peptide YY does not inhibit glucose-stimulated insulin secretion in humans. Eur. J. Endocrinol. 134:362-655
101. Ukkola OH, Puurunen VP, Piira OP, Niva JT, Lepojarvi ES, et al. 2011. High serum fasting peptide YY (3-36) is associated with obesity-associated insulin resistance and type 2 diabetes. Regul. Pept. 170:38-422
102. Fernandez-Garcia JC,Murri M, Coin-Araguez L, Alcaide J, El Bekay R, Tinahones FJ. 2013. GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects. Clin. Endocrinol. doi: 10.1111/cen.122211
103. Ahren B. 2011. The dynamic incretin adaptation and type 2 diabetes. J. Clin. Endocrinol. Metab. 96:620-222
104. Goumain M, Voisin T, Lorinet AM, Laburthe M. 1998. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon. Biochem. Biophys. Res. Commun. 247:52-566
105. Dumont Y, Moyse E, Fournier A, Quirion R. 2007. Distribution of peripherally injected peptide YY ([125I] PYY(3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema. J. Mol. Neurosci. 33:294-3044
106. Wang L, Gourcerol G, Yuan PQ, Wu SV, Million M, et al. 2010. Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice. Am. J. Physiol. Gastrointest. Liver Physiol. 298:G45-566
107. Stadlbauer U, Arnold M, Weber E, LanghansW. 2013. Possiblemechanisms of circulating PYY-induced satiation in male rats. Endocrinology 154:193-2044
108. Carr RD, LarsenMO, Jelic K, Lindgren O, Vikman J, et al. 2010. Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men. J. Clin. Endocrinol. Metab. 95:872-788
109. Carr RD, Larsen MO, Winzell MS, Jelic K, Lindgren O, et al. 2008. Incretin and islet hormonal responses to fat and protein ingestion in healthy men. Am. J. Physiol. Endocrinol. Metab. 295:E779-844
110. Mentlein R. 2009. Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP. Best Pract. Res. Clin. Endocrinol. Metab. 23:443-522
111. Plamboeck A, Veedfald S, Deacon CF, Hartmann B, Wettergren A, et al. 2013. The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty. Am. J. Physiol. Gastrointest. Liver Physiol. 304:G1117-277
112. Ghitza UE, Nair SG, Golden SA, Gray SM, Uejima JL, et al. 2007. Peptide YY3-36 decreases reinstatement of high-fat food seeking during dieting in a rat relapse model. J. Neurosci. 27:11522-322
113. D'Agostino AE, Small DM. 2012. Neuroimaging the interaction of mind and metabolism in humans. Mol. Metab. 1:10-200
114. Berthoud HR. 2011. Metabolic and hedonic drives in the neural control of appetite: Who is the boss? Curr. Opin. Neurobiol. 21:888-966
115. Kringelbach ML,O'Doherty J, Rolls ET, Andrews C. 2003. Activation of the human orbitofrontal cortex to a liquid food stimulus is correlated with its subjective pleasantness. Cereb. Cortex 13:1064-711
116. De Silva A, Salem V, Long CJ, Makwana A, Newbould RD, et al. 2011. The gut hormones PYY3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab. 14:700-66
117. Malik S, McGlone F, Bedrossian D, Dagher A. 2008. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab. 7:400-99
118. Perry JL, Joseph JE, Jiang Y, Zimmerman RS, Kelly TH, et al. 2011. Prefrontal cortex and drug abuse vulnerability: translation to prevention and treatment interventions. Brain Res. Rev. 65:124-499
119. Kringelbach ML, Rolls ET. 2004. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog. Neurobiol. 72:341-722
120. Weise CM, Thiyyagura P, Reiman EM, Chen K, Krakoff J. 2012. Postprandial plasma PYY concentrations are associated with increased regional gray matter volume and rCBF declines in caudate nuclei -a combined MRI and H2 15O PET study. Neuroimage 60:592-6000
121. Nonaka N, Shioda S, NiehoffML, BanksWA. 2003. Characterization of blood-brain barrier permeability to PYY3-36 in the mouse. J. Pharmacol. Exp. Ther. 306:948-533
122. Glavas MM, Grayson BE, Allen SE, Copp DR, Smith MS, et al. 2008. Characterization of brainstem peptide YY (PYY) neurons. J. Comp. Neurol. 506:194-2100
123. King NA, Burley VJ, Blundell JE. 1994. Exercise-induced suppression of appetite: effects on food intake and implications for energy balance. Eur. J. Clin. Nutr. 48:715-244
124. King JA, Wasse LK, Stensel DJ, Nimmo MA. 2013. Exercise and ghrelin: a narrative overview of research. Appetite 68:83-911
125. Martins C, Morgan LM, Bloom SR, Robertson MD. 2007. Effects of exercise on gut peptides, energy intake and appetite. J. Endocrinol. 193:251-588
126. ChengMH, Bushnell D, CannonDT, Kern M. 2009. Appetite regulation via exercise prior or subsequent to high-fat meal consumption. Appetite 52:193-988
127. King JA, Wasse LK, Ewens J, Crystallis K, Emmanuel J, et al. 2011. Differential acylated ghrelin, peptide YY3-36, appetite, and food intake responses to equivalent energy deficits created by exercise and food restriction. J. Clin. Endocrinol. Metab. 96:1114-211
128. Ueda SY, Yoshikawa T, Katsura Y, Usui T, Fujimoto S. 2009. Comparable effects of moderate intensity exercise on changes in anorectic gut hormone levels and energy intake to high intensity exercise. J. Endocrinol. 203:357-644
129. Deighton K, Karra E, Batterham RL, Stensel DJ. 2013. Appetite, energy intake and PYY336 responses to energy-matched continuous exercise and submaximal high intensity exercise. Appl. Physiol. Nutr.Metab. 38:947-522
130. Broom DR, Batterham RL, King JA, Stensel DJ. 2009. Influence of resistance and aerobic exercise on hunger, circulating levels of acylated ghrelin, and peptide YY in healthy males. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296:R29-355
131. Kawano H, Mineta M, Asaka M, MiyashitaM,Numao S, et al. 2013. Effects of different modes of exercise on appetite and appetite-regulating hormones. Appetite 66C:26-333
132. Holmstrup M, Fairchild T, Keslacy S, Weinstock R, Kanaley J. 2013. Satiety, but not total PYY, is increased with continuous and intermittent exercise. Obesity 21:2014-200
133. Hagobian TA, Yamashiro M, Hinkel-Lipsker J, Streder K, Evero N, Hackney T. 2013. Effects of acute exercise on appetite hormones and ad libitum energy intake in men and women. Appl. Physiol. Nutr. Metab. 38:66-722
134. Cooper JA, Watras AC, Paton CM,Wegner FH, Adams AK, Schoeller DA. 2011. Impact of exercise and dietary fatty acid composition from a high-fat diet on markers of hunger and satiety. Appetite 56:171-788
135. Larson-Meyer DE, Palm S, Bansal A, Austin KJ, Hart AM, Alexander BM. 2012. Influence of running and walking on hormonal regulators of appetite in women. J. Obes. 2012:7304099
136. GibbonsC,Caudwell P, FinlaysonG,WebbDL, Hellstrom PM, et al. 2013. Comparison of postprandial profiles of ghrelin, active GLP-1, and total PYY to meals varying in fat and carbohydrate and their association with hunger and the phases of satiety. J. Clin. Endocrinol. Metab. 98:E847-555
137. Deighton K, Barry R, ConnonCE, Stensel DJ. 2013. Appetite, gut hormone and energy intake responses to low volume sprint interval and traditional endurance exercise. Eur. J. Appl. Physiol. 113:1147-566
138. Russel RR, Willis KS, Ravussin E, Larson-Meyer ED. 2009. Effects of endurance running and dietary fat on circulating ghrelin and peptide YY. J. Sports Sci. Med. 8:574-833
139. WuT, Gao X, ChenM, van Dam RM. 2009. Long-term effectiveness of diet-plus-exercise interventions versus diet-only interventions for weight loss: a meta-analysis. Obes. Rev. 10:313-233
140. Ueda SY, Yoshikawa T, Katsura Y, Usui T, Nakao H, Fujimoto S. 2009. Changes in gut hormone levels and negative energy balance during aerobic exercise in obese young males. J. Endocrinol. 201:151-599
141. Jones TE, Basilio JL, Brophy PM, McCammonMR, Hickner RC. 2009. Long-term exercise training in overweight adolescents improves plasma peptide YY and resistin. Obesity 17:1189-955
142. Kelly KR,BrooksLM, Solomon TP, Kashyap SR, O'LearyVB, Kirwan JP. 2009. The glucose-dependent insulinotropic polypeptide and glucose-stimulated insulin response to exercise training and diet in obesity. Am. J. Physiol. Endocrinol. Metab. 296:E1269-744
143. Gueugnon C, Mougin F, Nguyen NU, Bouhaddi M, Nicolet-Guenat M, Dumoulin G. 2012. Ghrelin and PYY levels in adolescents with severe obesity: effects of weight loss induced by long-term exercise training and modified food habits. Eur. J. Appl. Physiol. 112:1797-8055
144. Guelfi KJ, Donges CE, Duffield R. 2013. Beneficial effects of 12 weeks of aerobic compared with resistance exercise training on perceived appetite in previously sedentary overweight and obese men. Metabolism 62:235-433
145. Martins C, Kulseng B, King NA,Holst JJ, Blundell JE. 2010. The effects of exercise-induced weight loss on appetite-related peptides and motivation to eat. J. Clin. Endocrinol. Metab. 95:1609-166
146. Hill BR, De SouzaMJ, Wagstaff DA, Sato R, Williams NI. 2012. 24-hour profiles of circulating ghrelin and peptide YY are inversely associated in normal weight premenopausal women. Peptides 38:159-622
147. Ellingsgaard H, Hauselmann I, Schuler B, Habib AM, Baggio LL, et al. 2011. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and cells. Nat. Med. 17:1481-899
148. Wong IP, Driessler F, Khor EC, Shi YC, Hormer B, et al. 2012. Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology. PLoS ONE 7:e400388
149. Reimann F, Tolhurst G, Gribble FM. 2012. G-protein-coupled receptors in intestinal chemosensation. Cell Metab. 15:421-311